エンドヌクレアースGは,心筋縮とミトコンドリア機能の新たな決定因子です
Chris McDermott-Roe1, Junmei Ye, Rizwan Ahmed
1Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 ONN, UK.
Nature
|October 8, 2011
まとめ
エンドヌクレアースG (Endog) の機能喪失変異により,左心室の質量が増加し,心臓の機能が低下します. この研究は,Endogを明らかにしています.
科学分野:
- 心血管遺伝学 心血管遺伝学
- ミトコンドリア生物学
- システム遺伝学 システム遺伝学
背景:
- 左心室質量 (LVM) は遺伝性であり,死亡リスク因子である.
- 遺伝的要因と心筋縮の規制メカニズムは十分に理解されていません.
- 全ゲノム関連研究は,LVMの遺伝的基盤を完全に特定していない.
研究 の 目的:
- 血圧独立の左心室質量に寄与する遺伝的要因を特定する.
- 心臓の縮と機能におけるエンドヌクレアースG (Endog) の役割を調査する.
- 心臓とミトコンドリア生物学におけるEndogの規制メカニズムを探求する.
主な方法:
- ラットモデルにおける応用統合型ゲノミクスとシステム遺伝学.
- Endog遺伝子の機能喪失変異を特定しました.
- カーディオミオサイト培養と,Endogが削除されたマウスモデルを使用した.
- ゲノム全体のネットワーク分析を行い,ミトコンドリア成分とのEndogの相互作用を研究しました.
主要な成果:
- Endogの機能喪失変異は,LVMの増加と心臓機能障害と関連していました.
- 心筋筋細胞におけるエンドッグ阻害は,プロハイパートロフィック刺激なしに高縮を促した.
- EndogはERR-αとPGC1αによって直接調節され,ミトコンドリアDNAと相互作用します.
- ネズミの内臓の欠損は,ミトコンドリアの枯渇,機能不全,ROSの産生を引き起こし,心筋細胞の拡大とステアトーシスを引き起こしました.
結論:
- エンドヌクレアースGは,不適応性心筋縮において新しい役割を果たします.
- ミトコンドリア機能障害と反応性酸素種は,心臓病と関連しています.
- Endogはミトコンドリア質量と心臓の機能の重要な調節剤です.
関連する概念動画
Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...


